
feb pm et
summari compani make proprietari discret mammographi x-ray bone densitomet
system diagnos monitor breast cancer osteoporosi metabol bone diseas
price-to-earnings oper ep
risk assess reflect particip
industri character rapid technolog chang new
industri standard new market entrant addit
compet number compani
significantli greater resourc product depth
includ ge siemen phillip fuji kodak toshiba
past perform indic futur perform reli upon
analysi prepar equiti analyst
aug pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
see
rais target
line peer fy sep
ep estim set fy
dec-q ep vs
ahead estim sale rose
organ growth yet oper
margin fell bp gross margin declin
bp due sale blood screen
busi cost rose
inclus cynosur medic aesthet
acquisit lift fy sep ep
guidanc lower
effect tax rate
feb ep estim base cfra oper earn
histor earn report compani report
cash dividend paid last year
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview histor compani develop manufactur market product
focus mammographi breast care osteoporosi assess follow octob
purchas cytyc corp compani also sell product cervic cancer screen treatment
excess menstrual bleed pre-term birth screen radiat treatment early-stag breast
cancer patient malign brain tumor juli purchas third wave
inc broaden reach clinic molecular diagnost
compani breast health busi offer broad portfolio breast imag relat product
accessori includ digit film-bas mammographi system magnet reson imag mri
breast coil computer-aid detect mammographi mri minim invas breast biopsi
devic breast biopsi site marker breast biopsi guidanc system breast imag comfort pad
breast brachytherapi product also develop new breast imag platform dimens
util new technolog tomosynthesi produc three dimension imag well
august acquir sentinel medic inc develop manufactur market mri
coil includ mri breast coil patient position visual softwar mri cad sentinel
medic develop advanc imag technolog use high-field strength mri system juli
acquir beij healthcom technolog compani ltd privat held manufactur
medic equip includ mammographi equip locat beij china oper
sentinel medic healthcom integr breast health segment
diagnost product segment offer product includ thinprep system primarili use
cytolog applic cervic cancer screen rapid fetal fibronectin test assist
physician assess risk pre-term birth molecular diagnost reagent use varieti
dna rna analysi applic base proprietari invad chemistri current molecular
diagnost offer base invad chemistri includ cervista hpv high risk cervista hpv
product assist diagnosi human papilloma viru hpv well product
diagnos cystic fibrosi cardiovascular risk diseas segment becam largest
follow acquisit gen-prob august
gyn surgic product includ novasur endometri ablat system myosur hysteroscop
tissu remov system decis ceas commerci april adiana
perman contracept novasur system minim invas procedur
treatment heavi menstrual bleed myosur system tissu remov devic design
provid incision-less remov fibroid polyp within uteru myosur system ad
gyn surgic product portfolio result januari acquisit interlac medic inc
adiana system form perman femal contracept intend altern tubal
compani skelet health unit offer dual-energi x-ray bone densitometri system
ultrasound-bas osteoporosi assess product fluoroscan mini c-arm imag product
market profil sold first fda-approv digit mammographi system januari
compet launch initi digit system two year earlier
rapid growth digit mammographi categori recent year convers
analog digit digit platform repres industri instal base first
offer digit system
competit landscap mammographi product subsystem compet product
offer number compani includ ge agfa siemen philip johnson johnson bard
cianna medic planm agfa kodak fuji im giotto sectra toshiba
held distributor medic product includ thinprep pap test relat instrument
diagnost surgic product tct oper subsidiari locat beij china acquisit
tct provid establish nationwid sale organ custom support
infrastructur china
august acquir gen-prob lead maker molecular diagnost product
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
slightli under-valued
neutral sinc februari technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
capit budget amid shift
procedur inpati outpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
sub-index increas vs rise
 composit index follow
rise health equip
index vs declin
composit index year date
juli health
equip index rose vs rise
 composit index
fundament outlook health care
equip sub-industri next month
neutral continu view mani product
categori histor recession-resist
expect continu grow albeit
slowli growth procedur rate
slow area normal view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped recent howev equip
maker think certain procedur rate may
stabil start recov
medic devic tax requir
healthcar reform law went effect
januari temporarili
suspend
elect donald trump republican
retain control congress believ
gop abil substanti alter
afford act includ potenti
elimin variou health care sector fee
tax although gop replac
remain uncertain believ
potenti fewer insur patient
neg impact equip sub-industri
fewer insur patient would like lead
fewer procedur anticip
hospit largest buyer
medic equip would also advers
impact could pressur
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
demand certain product categori
unfavor foreign exchang continu
hospit becom cautiou regard
base index
five-year market price perform feb
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
estim respect due sale blood
screen unit dec-q ep vs ahead estim
view sale blood screen unit posit saw limit volatil
sale growth sale rose diagnost breast health gyn
surgic skelet health fell updat fy sale guidanc
ep
account divestitur blood screen unit /jeffrey loo cfa
et capit iq keep hold opinion share
inc keep target price in-lin
peer revis fy sep ep estim
sep-q ep vs ahead estim initi fy
ep sale rose oper margin fell higher
 cost diagnost sale rose breast health gyn surgic
skelet health smallest unit fell encourag
broad base growth note volatil within blood screen
sale fell mainli order pattern partner grifol
analyst research note compani news
rais target line peer
fy sep ep estim set fy
dec-q ep vs ahead estim sale rose
organ growth yet oper margin fell bp gross
margin declin bp due sale blood screen busi
cost rose inclus cynosur medic aesthet
acquisit lift fy sep ep guidanc
lower effect tax rate fy /jeffrey
board director inc appoint namal nawana
director compani effect immedi mr nawana chief
execut offic presid aler inc acquir
octob mr nawana stand elect stockhold
compani annual meet stockhold
inc announc ericb compton
execut offic leav compani effect
prior separ mr compton serv compani
chief oper offic mr compton remain consult
compani
novemb elain ullian member board director
inc notifi compani decis stand re-elect
compani annual meet stockhold ms ullian
decis stand re-elect mark retir
board year distinguish servic involv
disagr board member manag
keep target in-lin peer
forward ep estim jun-q ep vs
estim sale account sale blood screen
unit acquisit cynosur rose well growth
forecast howev gross margin fell product mix blood screen
higher margin oper margin declin bp due inclus
cynosur expens encourag sale growth anticip lower
inc announc charl dockendorff elect
compani board director effect immedi mr dockendorff
also appoint compani audit financ committe mr
dockendorff year experi global healthcar
industri formerli execut vice presid chief offic
covidien public medic devic suppli compani acquir
covidien mr dockendorff respons global
financi plan investor relat well intern audit
march christoph coughlin member board director
inc notifi compani decis resign board
effect immedi mr coughlin decis relat compani
recent decis enter medic aesthet market complet
acquisit cynosur inc result potenti competit
compani allergan plc compani whose board mr coughlin serv
inc lower fy sep fy ep
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
